Millennium Management
ITOS

Millennium Management’s iTeos Therapeutics ITOS Stock Holding History

Millennium Management’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-20,000
Closed -$644K – 7214
2022
Q1 		$644K Buy
+20,000
New +$727K ﹤0.01% 4913

Other funds holding ITOS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Millennium Management's ITOS Position: Q3 2025 in Review

Millennium Management sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 477,189 shares — an estimated $4.76M sold.

Millennium Management first reported a position in ITOS in Q4 2020 and held it in 18 quarters. The position peaked at $17.1M in Q4 2022. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

  • Millennium Management reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Millennium Management sold 477,189 iTeos Therapeutics shares in Q3 2025, an estimated $4.76M.
  • Millennium Management first reported a position in iTeos Therapeutics in Q4 2020 and held it in 18 quarters.
  • Millennium Management's iTeos Therapeutics position peaked at $17.1M in Q4 2022.
  • 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.